IDVSmall business
IDC (single-award IDV) 75N95021D00024MURTY PHARMACEUTICALS, INC.
Overview
Award facts
- Obligated on orders under this IDV
- $1.01M
- $1,013,625 across 7 orders
- Period of performance
- From Sep 18, 2021
- Modifications
- 4
- Latest action Aug 22, 2024
- Contract type
- IDC (single-award IDV)
- PIID 75N95021D00024
Description of requirement
THE PURPOSE OF THIS CONTRACT IS TO CARRY OUT THE DEVELOPMENT AND MANUFACTURE OF PHARMACEUTICAL PREPARATIONS TO BE USED IN THE MEDICATIONS DEVELOPMENT PROGRAM FOR ADDICTION TREATMENT AT THE NATIONAL INSTITUTE ON DRUG ABUSE (NIDA).
Dates and value
- Award date
- Signed on Sep 17, 2021
- Ordering period ends
- Sep 17, 2026
- Ceiling
- Ceiling (single-award vehicle): $7,000,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 22, 2024. View on USAspending · Recipient on SAM.gov
Recipient
LocationLEXINGTON, KY
UEIDNJBTJ3XBQM6
CAGE code3BJ06
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyMURTY PHARMACEUTICALS, INC.
Business types and certifications
Minority-ownedSelf-certified small disadvantaged businessFor-profit organizationSubchapter S corporationCorporation (not tax-exempt)Manufacturer of goods
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIDA
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIDA
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 2
Solicitation and notices
- Solicitation ID
- 75N95020R00036
- Solicitation date
- Mar 2, 2021
- Notices
- Presolicitation posted Feb 12, 2021
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Development & manufacture of pharmaceutical products for the treatment of substance
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- Yes
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Transaction history
Modification history
- Base award
- Sep 17, 2021
- Latest action
- Aug 22, 2024 — Other administrative actionModification P00004; administrative: no change in scope or value
- Latest substantive action
- Jul 20, 2022 — Change orderModification P00003
- Actions by type
- Base award1
- Other administrative action3
- Change order1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
Structure
- Award or IDV
- IDV
- IDV type
- IDCB
- Indefinite-delivery contract type
- Indefinite delivery / indefinite quantityB
- Multiple or single award
- Single awardS
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N950
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N950